» Articles » PMID: 20671926

Promoter Variant of PIK3C3 is Associated with Autoimmunity Against Ro and Sm Epitopes in African-American Lupus Patients

Overview
Specialty Biology
Date 2010 Jul 31
PMID 20671926
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The PIK3C3 locus was implicated in case-case genome-wide association study of systemic lupus erythematosus (SLE) which we had performed to detect genes associated with autoantibodies and serum interferon-alpha (IFN-alpha). Herein, we examine a PIK3C3 promoter variant (rs3813065/-442 C/T) in an independent multiancestral cohort of 478 SLE cases and 522 controls. rs3813065 C was strongly associated with the simultaneous presence of both anti-Ro and anti-Sm antibodies in African-American patients [OR = 2.24 (1.34-3.73), P = 2.0 x 10(-3)]. This autoantibody profile was associated with higher serum IFN-alpha (P = 7.6 x 10(-6)). In the HapMap Yoruba population, rs3813065 was associated with differential expression of ERAP2 (P = 2.0 x 10(-5)), which encodes an enzyme involved in MHC class I peptide processing. Thus, rs3813065 C is associated with a particular autoantibody profile and altered expression of an MHC peptide processing enzyme, suggesting that this variant modulates serologic autoimmunity in African-American SLE patients.

Citing Articles

Pharmacological insights into autophagy modulation in autoimmune diseases.

Wu M, Wang E, Feng D, Li M, Ye R, Lu J Acta Pharm Sin B. 2021; 11(11):3364-3378.

PMID: 34900523 PMC: 8642426. DOI: 10.1016/j.apsb.2021.03.026.


Pathogenic Single Nucleotide Polymorphisms on Autophagy-Related Genes.

Tamargo-Gomez I, Fernandez A, Marino G Int J Mol Sci. 2020; 21(21).

PMID: 33147747 PMC: 7672651. DOI: 10.3390/ijms21218196.


Analysis of Natural Selection of Immune Genes in by Transcriptome Sequencing.

Tuo Y, Chu W, Zhang J, Cheng J, Chen L, Bao L Front Genet. 2020; 11:714.

PMID: 32793279 PMC: 7393255. DOI: 10.3389/fgene.2020.00714.


Meta-analysis of genomic variants and gene expression data in schizophrenia suggests the potential need for adjunctive therapeutic interventions for neuropsychiatric disorders.

Anirudh Chellappa S, Pathak A, Sinha P, Jainarayanan A, Jain S, Brahmachari S J Genet. 2019; 98(2).

PMID: 31204709


I too, am America: a review of research on systemic lupus erythematosus in African-Americans.

Williams E, Bruner L, Adkins A, Vrana C, Logan A, Kamen D Lupus Sci Med. 2016; 3(1):e000144.

PMID: 27651918 PMC: 5013381. DOI: 10.1136/lupus-2015-000144.


References
1.
Ippolito A, Petri M . An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol. 2008; 26(5 Suppl 51):S72-9. View

2.
Salloum R, Franek B, Kariuki S, Rhee L, Mikolaitis R, Jolly M . Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 2010; 62(2):553-61. PMC: 2832192. DOI: 10.1002/art.27182. View

3.
Duan S, Gao R, Xing Q, Du J, Liu Z, Chen Q . A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci Lett. 2005; 379(1):32-6. DOI: 10.1016/j.neulet.2004.12.040. View

4.
Saito T, Aghalar M, Lachman H . Analysis of PIK3C3 promoter variant in African-Americans with schizophrenia. Schizophr Res. 2005; 76(2-3):361-2. DOI: 10.1016/j.schres.2005.01.002. View

5.
Kariuki S, Niewold T . Genetic regulation of serum cytokines in systemic lupus erythematosus. Transl Res. 2010; 155(3):109-17. PMC: 2827336. DOI: 10.1016/j.trsl.2009.08.012. View